<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>新康界 | wechat-feeds</title><link>http://MzA5ODEzOTYxNg.favicon.privacyhide.com/favicon.ico</link><description>中康资讯旗下品牌，中国领先的医药健康产业财经新媒体。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 02 Jun 2021 20:07:29 +0800</pubDate><image><url>http://MzA5ODEzOTYxNg.favicon.privacyhide.com/favicon.ico</url><title>新康界 | wechat-feeds</title><link>http://MzA5ODEzOTYxNg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>瓜分2440亿美元市场蛋糕，谁会是国内CXO独角兽？药明康德、泰格、凯莱英......</title><link>https://mp.weixin.qq.com/s/VJO_mGMl34Yyd0PAuZa6uw</link><description></description><content:encoded><![CDATA[瓜分2440亿美元市场蛋糕，谁会是国内CXO独角兽？药明康德、泰格、凯莱英......]]></content:encoded><pubDate>Wed, 02 Jun 2021 19:24:21 +0800</pubDate></item><item><title>新冠检测产品被FDA召回，乐普医疗火速回应，专业人士：影响不大！</title><link>https://mp.weixin.qq.com/s/ORxNZNjMPIxponk8T0Y2zg</link><description></description><content:encoded><![CDATA[新冠检测产品被FDA召回，乐普医疗火速回应，专业人士：影响不大！]]></content:encoded><pubDate>Mon, 31 May 2021 18:52:15 +0800</pubDate></item><item><title>大健康产业投资并购动态周报Vol.51</title><link>https://mp.weixin.qq.com/s/aCykE5qCX1K9FPMB7JtbjA</link><description></description><content:encoded><![CDATA[大健康产业投资并购动态周报Vol.51]]></content:encoded><pubDate>Mon, 31 May 2021 18:52:15 +0800</pubDate></item><item><title>高端访谈|荣昌生物房健民：创新药需优化创新环境，提升风险承受力及科研转化率！</title><link>https://mp.weixin.qq.com/s/G10OTsMw4gMfBx3uoQwoNA</link><description></description><content:encoded><![CDATA[高端访谈|荣昌生物房健民：创新药需优化创新环境，提升风险承受力及科研转化率！]]></content:encoded><pubDate>Thu, 27 May 2021 19:19:05 +0800</pubDate></item><item><title>为新药与患者搭桥，“患者服务与新药上市论坛”在京召开</title><link>https://mp.weixin.qq.com/s/PifrmiF0aEJKERtRUdmENA</link><description></description><content:encoded><![CDATA[为新药与患者搭桥，“患者服务与新药上市论坛”在京召开]]></content:encoded><pubDate>Thu, 27 May 2021 19:19:05 +0800</pubDate></item><item><title>远超预期！中国生物制药透露新冠疫苗到底有多赚钱！</title><link>https://mp.weixin.qq.com/s/jx-Kl_Nc7LMI4D6bbBY7kw</link><description></description><content:encoded><![CDATA[远超预期！中国生物制药透露新冠疫苗到底有多赚钱！]]></content:encoded><pubDate>Tue, 25 May 2021 07:42:51 +0800</pubDate></item><item><title>研发支出超营收、研发人员占比超三成，头部创新药企研发实力哪家强？</title><link>https://mp.weixin.qq.com/s/GTTmuoIzAglRXJvryACgsg</link><description></description><content:encoded><![CDATA[研发支出超营收、研发人员占比超三成，头部创新药企研发实力哪家强？]]></content:encoded><pubDate>Mon, 24 May 2021 17:59:06 +0800</pubDate></item><item><title>大健康产业投资并购动态周报Vol.50</title><link>https://mp.weixin.qq.com/s/ZNGv9uilZBgGlJHnKzUqPg</link><description></description><content:encoded><![CDATA[大健康产业投资并购动态周报Vol.50]]></content:encoded><pubDate>Mon, 24 May 2021 17:59:06 +0800</pubDate></item><item><title>19.5亿上位科华生物最大股东，IVD新贵圣湘生物在下一盘什么样的棋？</title><link>https://mp.weixin.qq.com/s/lI4U4z6lMCmSbwib_AeuLQ</link><description></description><content:encoded><![CDATA[19.5亿上位科华生物最大股东，IVD新贵圣湘生物在下一盘什么样的棋？]]></content:encoded><pubDate>Thu, 20 May 2021 18:21:38 +0800</pubDate></item><item><title>复星医药与BioNTech强强联合推动mRNA疫苗本土化，短期有望增利数十亿元</title><link>https://mp.weixin.qq.com/s/6uhuHIoGOTYlY_ZHbSRhnQ</link><description></description><content:encoded><![CDATA[复星医药与BioNTech强强联合推动mRNA疫苗本土化，短期有望增利数十亿元]]></content:encoded><pubDate>Wed, 19 May 2021 18:26:27 +0800</pubDate></item><item><title>似降实增，波澜不惊——拜耳2021Q1业绩解读</title><link>https://mp.weixin.qq.com/s/83ygf0dK38XGDE3srKDIZQ</link><description></description><content:encoded><![CDATA[似降实增，波澜不惊——拜耳2021Q1业绩解读]]></content:encoded><pubDate>Tue, 18 May 2021 18:21:48 +0800</pubDate></item><item><title>抢先看！迈瑞国产替代及国际化进程提速，斥资42亿收购IVD原材料公司</title><link>https://mp.weixin.qq.com/s/REzBgo_ULtJ3VmXVaWFhJg</link><description></description><content:encoded><![CDATA[抢先看！迈瑞国产替代及国际化进程提速，斥资42亿收购IVD原材料公司]]></content:encoded><pubDate>Mon, 17 May 2021 12:06:49 +0800</pubDate></item><item><title>大健康产业投资并购动态周报Vol.49</title><link>https://mp.weixin.qq.com/s/ec4wg-HmkONgGK1VUzgimg</link><description></description><content:encoded><![CDATA[大健康产业投资并购动态周报Vol.49]]></content:encoded><pubDate>Mon, 17 May 2021 12:06:49 +0800</pubDate></item><item><title>“重启”渐进！*ST康美破产重整或引入战投，有望摆脱困境涅槃重生</title><link>https://mp.weixin.qq.com/s/k0nNc11EffrxrGwZejkfaQ</link><description></description><content:encoded><![CDATA[“重启”渐进！*ST康美破产重整或引入战投，有望摆脱困境涅槃重生]]></content:encoded><pubDate>Sat, 15 May 2021 17:56:11 +0800</pubDate></item></channel></rss>